NVIDIA
NVDA
Tesla
TSLA
Broadcom
AVGO
4
Palantir
PLTR
5
Gorilla Technology
GRRR
US Stock MarketDetailed Quotes
CANF Can-Fite BioPharma
- 1.5800
- -0.0200-1.25%
Close Mar 7 16:00 ET
- 1.5419
- -0.0381-2.41%
Post 20:01 ET
9.63MMarket Cap-0.61P/E (TTM)
1.7600High1.5400Low32.66KVolume1.5600Open1.6000Pre Close52.11KTurnover0.54%Turnover RatioLossP/E (Static)6.10MShares4.690052wk High3.88P/B9.63MFloat Cap1.290052wk Low--Dividend TTM6.10MShs Float1419.0000Historical High--Div YieldTTM13.75%Amplitude1.2900Historical Low1.5950Avg Price1Lot Size
About Can-Fite BioPharma Company
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602. The company was founded by Pnina Fishman and Ilan Cohn on September 11, 1994 and is headquartered in Petach-Tikva, Israel.
Company Profile
SymbolCANF
Company NameCan-Fite BioPharma
Listing DateSep 10, 2012
Founded1994
CEOMr. Motti Farbstein
MarketAMEX
Employees5
Securities TypeDR
ADS Ratio1.0 : 300.0
Fiscal Year Ends12-31
Address26 Ben Gurion Street
CityRamat Gan
CountryIsrael
Zip Code5257346
Phone972-3-924-1114
Websitehttp://www.canfite.com
Company Executives
- Name
- Position
- Salary
- Motti Farbstein
- Chief Executive Officer, Chief Operating and Financial Officer
- 467.00K
- Dr. Pnina Fishman, PhD
- Chief Scientific Officer and Executive Chairman of the Board
- 703.00K
- Dr. Sari Fishman, PhD
- Vice President, Business Development
- 373.00K
- Dr. Ilan Cohn, PhD
- Director
- --
- Dr. Abraham Sartani
- Director
- --
- Yaacov Goldman
- Independent Director
- 60.00K
- Yoseph Bornstein
- Independent Director
- --
- Guy Regev
- Independent Director
- 60.00K